Ovixan (Mometasone Furoate)

Mometasone furoate, the active ingredient in Ovixan, is a corticosteroid presented as a topical formulation for dermatological use. It is employed to treat inflammatory skin conditions such as eczema, psoriasis and allergic dermatitis in adult and pediatric patients. GNH USA supplies Ovixan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Ovixan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Ovixan is a potent corticosteroid that acts on inflammatory skin pathways to reduce redness, swelling and itching. - Atopic dermatitis: helps control flare‑ups and reduces itch in mild to moderate disease. - Psoriasis plaque: decreases scaling and erythema in affected plaques. - Contact dermatitis: relieves allergic skin reactions and accelerates lesion healing.

Adverse reactions are generally limited to the application site, though systemic absorption can occur with extensive use.

Common Side Effects: - Burning or stinging sensation at the site of application. - Pruritus or mild itching. - Dryness or flaking of the skin. - Erythema or mild redness. - Folliculitis or small pustules. - Acneiform eruptions.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Telangiectasia (visible small blood vessels). - Hypopigmentation or depigmentation. - Contact dermatitis to the formulation. - Secondary bacterial, fungal or viral skin infection. - Systemic effects such as adrenal suppression with extensive application.

When using Ovixan, consider the following safety measures: - Apply only to intact skin: avoid broken or infected areas. - Limit duration: do not exceed the prescribed treatment period. - Use the smallest effective amount: apply a thin layer to the affected area. - Avoid occlusive dressings: unless directed by a clinician. - Monitor for signs of systemic absorption: especially in children or extensive body‑surface use. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Mometasone furoate may interact with other topical or systemic agents that influence skin integrity or cortisol metabolism.

Major Interactions (Avoid):\n- Concurrent use of other potent topical corticosteroids on the same area. - Systemic corticosteroids that may increase risk of adrenal suppression. - Antifungal or antibacterial creams containing high‑potency irritants.

Moderate Interactions (Monitor Closely): - Skin‑lightening agents (hydroquinone) that may increase irritation. - Retinoids (tretinoin) applied to adjacent areas. - Non‑steroidal anti‑inflammatory drugs (topical NSAIDs) used nearby. - Herbal or cosmetic products that may alter barrier function.